Stockscreener 앱 받기
2.38
8.11%
-0.21
시간 외 거래:
2.38
전일 마감가:
$2.59
열려 있는:
$2.5
하루 거래량:
315.36K
Relative Volume:
0.70
시가총액:
$250.41M
수익:
$7.05M
순이익/손실:
$-30.43M
주가수익비율:
-6.283
EPS:
-0.3788
순현금흐름:
$21.84M
1주 성능:
-16.49%
1개월 성능:
-2.86%
6개월 성능:
+19.60%
1년 성능:
-34.44%
1일 변동 폭
$2.37
$2.65
1주일 범위
$2.37
$2.84
52주 변동 폭
$1.07
$4.21
Proqr Therapeutics N V Stock (PRQR) Company Profile
PRQR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.38 | 272.84M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-04-29 | 개시 | Evercore ISI | Outperform |
| 2025-03-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-29 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-02-01 | 개시 | Raymond James | Strong Buy |
| 2021-05-03 | 개시 | Stifel | Buy |
| 2021-03-25 | 재확인 | Citigroup | Buy |
| 2020-11-03 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-03-12 | 재확인 | Chardan Capital Markets | Buy |
| 2018-12-19 | 개시 | RBC Capital Mkts | Outperform |
| 2018-11-15 | 개시 | Citigroup | Buy |
| 2018-09-19 | 개시 | Evercore ISI | Outperform |
| 2017-09-26 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-06-20 | 개시 | Chardan Capital Markets | Neutral |
| 2014-10-15 | 개시 | Deutsche Bank | Buy |
| 2014-10-13 | 개시 | H.C. Wainwright | Buy |
모두보기
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
ProQR Therapeutics (PRQR) Receives "Buy" Rating from Chardan Cap - GuruFocus
Earnings visualization tools for ProQR Therapeutics N.V.Share Buyback & Daily Volume Surge Trade Alerts - newser.com
Will ProQR Therapeutics N.V. (0PQ) stock enhance shareholder valueJuly 2025 Short Interest & Proven Capital Preservation Methods - newser.com
Is ProQR Therapeutics N.V. stock a good choice for value investors2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Regression analysis insights on ProQR Therapeutics N.V. performanceGlobal Markets & Fast Gain Stock Tips - newser.com
Can ProQR Therapeutics N.V. (0PQ) stock ride next bull market cycle2025 Stock Rankings & High Yield Equity Trading Tips - newser.com
Pattern recognition hints at ProQR Therapeutics N.V. upside2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Using Bollinger Bands to evaluate ProQR Therapeutics N.V.July 2025 Fed Impact & Growth Focused Entry Point Reports - newser.com
Why ProQR Therapeutics N.V. is moving todayTreasury Yields & Fast Entry High Yield Stock Tips - newser.com
Will ProQR Therapeutics N.V. stock outperform international peersRate Cut & Weekly Breakout Watchlists - newser.com
What’s the recovery path for long term holders of ProQR Therapeutics N.V.2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
Key metrics from ProQR Therapeutics N.V.’s quarterly dataEarnings Recap Report & Smart Money Movement Tracker - newser.com
ProQR Advances AX-0810 into Clinical Trials for Cholestatic Diseases - TipRanks
Transcript : ProQR Therapeutics N.V.Shareholder/Analyst Call - MarketScreener
How ProQR Therapeutics N.V. (0PQ) stock compares with tech leadersJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Custom watchlist performance reports with ProQR Therapeutics N.V.Weekly Stock Summary & Technical Confirmation Trade Alerts - newser.com
Is ProQR Therapeutics N.V. stock cheap at current valuationOptions Play & Expert-Curated Trade Recommendations - newser.com
Does ProQR Therapeutics N.V. stock trade at a discount to peers - newser.com
Will ProQR Therapeutics N.V. stock gain from government policiesMarket Volume Report & Stock Timing and Entry Methods - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Up 80.2% in October - Defense World
Is ProQR Therapeutics N.V. stock attractive for growth ETFsMarket Movers & Weekly Consistent Profit Watchlists - newser.com
Why analysts recommend ProQR Therapeutics N.V. (0PQ) stockQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
What catalysts could drive ProQR Therapeutics N.V. stock higherWeekly Loss Report & Consistent Return Strategy Ideas - newser.com
How sentiment analysis helps forecast ProQR Therapeutics N.V.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Update - MarketBeat
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Visualizing ProQR Therapeutics N.V. stock with heatmapsTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Is ProQR Therapeutics N.V. (0PQ) stock at risk of policy regulation2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Proqr Therapeutics N V (PRQR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):